Primary Epstein–Barr virus infection and recurrent type I membranoproliferative glomerulonephritis after renal transplantation

Margret B. Andresdottir, Karel J. M. Assmann, Luuk B. Hilbrands, Jack F. M. Wetzels
2000 Nephrology, Dialysis and Transplantation  
Keywords: Epstein-Barr virus; membranoproliferative hepatitis C. The basic immunosuppressive therapy glomerulonephritis; transplantation consisted of cyclosporin (CsA) (10 mg/kg, tapered to 4 mg/kg at 3 months) and prednisone (100 mg/day for the first 3 days, tapered to 0.15 mg/kg at 4 months). There was an immediate graft function and the early
doi:10.1093/ndt/15.8.1235 pmid:10910452 fatcat:n6h4sc6cd5a4pd53yrscgpxige